Back to Screener

Technology

Avai Bio, Inc.(AVAI)

Live Price

Offline

$0.1451

-12.06% today

1Y Change

-70.00%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$50.00M
Revenue Growth
0.0%
EPS Growth
+63.8%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Avai Bio, Inc. (AVAI) is a Technology stock with a market cap of $50.00M. The stock last traded around $0.15 and down 70.0% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +63.8%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +63.8%, free cash flow +21.1% with operating margin 0.0% and ROIC 75.7%. Stock Foundry combines AVAI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.

Benchmark Edge

AVAI vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

AVAI

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

AVAI Max Drawdown

-80.69%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for AVAI and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Avai Bio, Inc. (AVAI)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$1.2M

+31.8% YoY

FY Net Income

-$302.3K

-138.9% YoY

Free Cash Flow

-$16.2K

+89.4% YoY

Revenue Growth

+0.0%

EPS Growth

+63.8%

Gross Margin

0.0%

Net Margin

0.0%

Income statement

USD

Annual
Metric20252024202320222021
Revenue00276K921K1M
Gross Profit-74K-77K-64K163K-73K
Operating Income-2M-2M-364K-343K-304K
EBITDA-1M-2M-326K-79K-246K
Net Income-1M-2M-349K-127K-302K
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents81K281107K33K60K
Total Assets225K322K241K455K816K
Total Liabilities2M2M875K860K1M
Shareholder Equity-2M-1M-633K-406K-327K
Total Debt903K707K638K600K424K
Net Debt822K706K530K567K363K

Cash flow positioning

Latest Full Year

Operating Cash Flow

16K

+89.4% YoY

Capital Expenditures

0

Free Cash Flow

16K

+89.4% YoY

Key ratios

  • Gross Margin

    0.0%

  • Operating Margin

    0.0%

  • Net Margin

    0.0%

  • ROE

    47.6%

  • Debt / Equity

    -0.56x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.